logo
  

Dangdang Posts Profit In Q3 - Quick Facts

E-Commerce China Dangdang Inc.'s (DANG) third-quarter 2014 net income was RMB24.5 million or $4.0 million, as compared with a net loss of RMB27.9 million in the prior-year quarter. Quarterly earnings per ADS were RMB0.29 or $0.05, as against a loss per ADS of RMB0.35 last year.

Net income, excluding share-based compensation expenses, was RMB26.7 million, or $4.3 million for the recent quarter. Non-GAAP earnings per ADS were RMB0.32, or $0.05 during the latest period.

Total net revenues for the quarter reached RMB2.0 billion or $326.3 million, a 31.3% increase from the corresponding period in 2013.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT